Zacks62d agoneutral
Why Is Ocugen (OCGN) Down 10.7% Since Last Earnings Report?Ocugen (OCGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
472last 24h
2479last 7d
470● bullish (7d)
249● bearish (7d)
198publishers
Insider Monkey84d agoneutral
Ocugen (OCGN) Reports Q1 EPSOcugen, Inc. (NASDAQ:OCGN) is one of the 10 Best Penny Stocks to Buy Before They Explode. On May 5, 2026, Ocugen, Inc. (NASDAQ:OCGN) reported Q1 EPS of (6c), versus the consensus estimate of (5c). Revenue totaled $1.53M, versus the consensus estimate of $358,140. Chairman, CEO, and Co-Founder Dr. Shankar Musunuri said the company completed enrollment […]
MarketBeat92d agoneutral
Ocugen Q1 Earnings Call HighlightsOcugen (NASDAQ:OCGN) used its first-quarter 2026 earnings call to highlight progress across its retinal gene therapy pipeline and to outline a strengthened balance sheet following a newly announced financing. Convertible notes offering and cash runway outlook Chairman, CEO, and Co-founder Dr. Shank